Managing Treatment-Resistant Depression
Road to Novel Therapeutics
Herausgeber: Quevedo, Joao L de; Bobo, William V; Riva-Posse, Patricio
Managing Treatment-Resistant Depression
Road to Novel Therapeutics
Herausgeber: Quevedo, Joao L de; Bobo, William V; Riva-Posse, Patricio
- Broschiertes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Managing Treatment-Resistant Depression: Road to Novel Therapeutics defines TRD for readers, discussing the clinical and epidemiological predictors, economic burden and neurobiological factors. In addition, staging methods for treatment resistance are fully covered in this book, including serotonin specific reuptake inhibitors, serotonin norepinephrine reuptake inhibitors, other classes of antidepressants, including tricyclic antidepressants and monoamine oxidase inhibitors, augmentation strategies, and newer antidepressant treatments like ketamine and esketamine. In addition, evidence…mehr
- Justin R YatesDeterminants of Addiction125,99 €
- Patrick W StromanEssentials of Functional MRI123,99 €
- Biochemical Immunology of Diabetes and Associated Complications171,99 €
- Melatonin92,99 €
- Raj KumarSteroid Hormone Receptors in Health and Disease158,99 €
- Diabetes Mellitus135,99 €
- Psychological and Medical Perspectives on Fertility Care and Sexual Health135,99 €
-
-
-
- Produktdetails
- Verlag: Elsevier Health Sciences
- Seitenzahl: 612
- Erscheinungstermin: 4. April 2022
- Englisch
- Abmessung: 276mm x 216mm
- Gewicht: 1650g
- ISBN-13: 9780128240670
- ISBN-10: 0128240679
- Artikelnr.: 62234576
- Verlag: Elsevier Health Sciences
- Seitenzahl: 612
- Erscheinungstermin: 4. April 2022
- Englisch
- Abmessung: 276mm x 216mm
- Gewicht: 1650g
- ISBN-13: 9780128240670
- ISBN-10: 0128240679
- Artikelnr.: 62234576
and staging treatment intensity
2. Clinical and epidemiological predictors of treatment-resistant
depression
3. The economic burden of treatment-resistant depression: Cost-of-illness
perspective
4. The neurobiology of treatmentresistant depression
5. Modeling treatment-resistant depression in the preclinical setting
6. Treatment algorithms for treatment-resistant depression
7. Tools to aid precision treatments to prevent or manage
treatmentresistant depression (TRD): Pharmacogenomics, machine learning,
and artificial intelligence
8. Tricyclic antidepressants for treatment-resistant depression
9. Monoamine oxidase inhibitors for treatment-resistant depression
10. Switching antidepressants in patients with treatment-resistant
depression
11. Adjunctive strategies for treatment-resistant depression
12. Combining antidepressants to address treatment-resistant depression
13. Ketamine/esketamine for treatment-resistant depression
14. Psychedelic agents for treatmentresistant depression
15. Inflammation and treatment resistance: Mechanisms and treatment
implications
16. Opioid agents for treatmentresistant depression
17. Transcranial magnetic stimulation for treatment-resistant depression
18. tDCS for treatment-resistant depression
19. ECT for treatment-resistant depression
20. MST for treatment-resistant depression
21. VNS for treatment-resistant depression
22. Deep brain stimulation for treatment-resistant depression
23. Other neurosurgical interventions for treatment-resistant depression
24. Treatment-resistant psychotic depression
25. Evidence-based psychotherapy for treatment-resistant depression
26. Treatment-resistant bipolar depression
27. Treatment-resistant depression in child and adolescents
28. Treatment-resistant depression in geriatrics
29. Identification and management of anxious depression in patients with
treatment-resistant depression
30. Managing treatment-resistant depression with comorbid personality
disorders
31. Managing treatment-resistant depression with comorbid substance use
disorders
32. Managing treatment-resistant depression in the setting of chronic pain
33. Inhaled gases for treatmentresistant major depression
34. Drugs under investigation for treatment-resistant depression
35. Chronotherapeutics for treatmentresistant depression
36. Managing treatment resistant depression in primary care settings
37. Treatment-resistant depression in pregnancy, the postpartum period, and
transition to menopause
38. Lifestyle interventions for treatment-resistant depression
39. Managing the risk of suicide in people with treatment-resistant
depression
40. Maintaining motivation and preserving the therapeutic alliance as tools
to overcome treatmentresistant depression
and staging treatment intensity
2. Clinical and epidemiological predictors of treatment-resistant
depression
3. The economic burden of treatment-resistant depression: Cost-of-illness
perspective
4. The neurobiology of treatmentresistant depression
5. Modeling treatment-resistant depression in the preclinical setting
6. Treatment algorithms for treatment-resistant depression
7. Tools to aid precision treatments to prevent or manage
treatmentresistant depression (TRD): Pharmacogenomics, machine learning,
and artificial intelligence
8. Tricyclic antidepressants for treatment-resistant depression
9. Monoamine oxidase inhibitors for treatment-resistant depression
10. Switching antidepressants in patients with treatment-resistant
depression
11. Adjunctive strategies for treatment-resistant depression
12. Combining antidepressants to address treatment-resistant depression
13. Ketamine/esketamine for treatment-resistant depression
14. Psychedelic agents for treatmentresistant depression
15. Inflammation and treatment resistance: Mechanisms and treatment
implications
16. Opioid agents for treatmentresistant depression
17. Transcranial magnetic stimulation for treatment-resistant depression
18. tDCS for treatment-resistant depression
19. ECT for treatment-resistant depression
20. MST for treatment-resistant depression
21. VNS for treatment-resistant depression
22. Deep brain stimulation for treatment-resistant depression
23. Other neurosurgical interventions for treatment-resistant depression
24. Treatment-resistant psychotic depression
25. Evidence-based psychotherapy for treatment-resistant depression
26. Treatment-resistant bipolar depression
27. Treatment-resistant depression in child and adolescents
28. Treatment-resistant depression in geriatrics
29. Identification and management of anxious depression in patients with
treatment-resistant depression
30. Managing treatment-resistant depression with comorbid personality
disorders
31. Managing treatment-resistant depression with comorbid substance use
disorders
32. Managing treatment-resistant depression in the setting of chronic pain
33. Inhaled gases for treatmentresistant major depression
34. Drugs under investigation for treatment-resistant depression
35. Chronotherapeutics for treatmentresistant depression
36. Managing treatment resistant depression in primary care settings
37. Treatment-resistant depression in pregnancy, the postpartum period, and
transition to menopause
38. Lifestyle interventions for treatment-resistant depression
39. Managing the risk of suicide in people with treatment-resistant
depression
40. Maintaining motivation and preserving the therapeutic alliance as tools
to overcome treatmentresistant depression